Walpar Nutritions Ltd

Walpar Nutrition Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Walpar Nutritions Ltd

₹ 45.5 -4.91%
29 Jan 2026
walparnutritions.com NSE - SME: WALPAR
About

Incorporated in 2009, Walpar Nutritions Ltd manufactures and trades Pharmaceutical, Nutraceutical, Herbal and Ayurvedic commodities[1]

Key Points

Business Overview:[1]
Company manufactures and sells Nutraceutical and Herbal dietary supplement formulations, ingredients and research. It manufactures private label brands for different companies and its own brands, selling through online and direct channels. Company is a specialized Contract manufacturer for different formulation in Nutraceuticals and Herbal products

Website NSE - SM
  • Market Cap ₹ 42.7 Cr.
  • Current Price ₹ 45.5
  • High / Low ₹ 53.3 / 37.7
  • Stock P/E 18.3
  • Book Value ₹ 18.9
  • Dividend Yield 0.00 %
  • ROCE 16.1 %
  • ROE 15.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 57.9 days to 42.2 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 11.2% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
13.98 13.98 12.78 16.52 18.62 31.14 31.38 32.53 39.24 36.49
13.47 13.47 12.27 15.52 16.12 29.15 28.62 29.89 36.16 33.55
Operating Profit 0.51 0.51 0.51 1.00 2.50 1.99 2.76 2.64 3.08 2.94
OPM % 3.65% 3.65% 3.99% 6.05% 13.43% 6.39% 8.80% 8.12% 7.85% 8.06%
0.04 0.04 -0.02 0.05 0.27 0.06 0.16 0.31 -0.04 0.13
Interest 0.25 0.25 0.24 0.44 0.36 0.33 0.34 0.26 0.03 0.30
Depreciation 0.13 0.13 0.15 0.84 1.07 0.92 0.89 0.88 0.94 1.00
Profit before tax 0.17 0.17 0.10 -0.23 1.34 0.80 1.69 1.81 2.07 1.77
Tax % 29.41% 29.41% -130.00% 39.13% 15.67% 20.00% 23.08% 22.10% 32.85% 15.25%
0.12 0.12 0.24 -0.33 1.14 0.65 1.29 1.41 1.39 1.50
EPS in Rs 0.19 0.14 0.27 -0.42 1.07 0.43 1.26 1.37 1.11 1.37
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
6.07 26.76 35.14 62.52 71.76 75.73
5.61 25.74 31.65 57.77 66.04 69.71
Operating Profit 0.46 1.02 3.49 4.75 5.72 6.02
OPM % 7.58% 3.81% 9.93% 7.60% 7.97% 7.95%
0.00 0.02 0.32 0.22 0.27 0.09
Interest 0.18 0.48 0.79 0.67 0.29 0.33
Depreciation 0.12 0.28 1.91 1.81 1.82 1.94
Profit before tax 0.16 0.28 1.11 2.49 3.88 3.84
Tax % 6.25% -32.14% 27.03% 22.09% 27.84%
0.15 0.36 0.81 1.94 2.79 2.89
EPS in Rs 0.22 0.42 0.65 1.68 2.47 2.48
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 39%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 81%
TTM: -6%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 22%
1 Year: 1%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 11%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 3.34 4.54 4.54 4.70 9.39 9.39
Reserves 1.44 6.45 7.17 9.49 7.17 8.36
7.49 7.25 10.30 8.30 7.85 8.48
5.73 9.85 12.29 14.67 22.98 27.68
Total Liabilities 18.00 28.09 34.30 37.16 47.39 53.91
1.70 2.01 10.13 10.20 10.65 11.42
CWIP 1.22 4.48 0.02 0.02 0.03 0.00
Investments 0.00 0.49 0.02 1.88 1.88 2.24
15.08 21.11 24.13 25.06 34.83 40.25
Total Assets 18.00 28.09 34.30 37.16 47.39 53.91

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.31 -1.08 1.10 5.35 4.06
-2.02 -6.14 -3.44 -3.61 -2.30
2.95 6.71 2.42 -1.77 -0.68
Net Cash Flow 0.62 -0.51 0.07 -0.03 1.08

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 430.54 124.26 129.63 78.46 107.73
Inventory Days 369.26 103.22 128.73 67.15 67.85
Days Payable 455.40 135.07 143.88 72.94 108.50
Cash Conversion Cycle 344.41 92.41 114.48 72.67 67.07
Working Capital Days 316.29 61.65 87.87 43.55 42.17
ROCE % 4.85% 8.78% 12.75% 16.08%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Domestic Sales Revenue
Rs. in Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Employee Benefit Expenses
Rs. in Lakhs
Export Sales Revenue
Rs. in Lakhs
Trade Receivables Turnover Ratio
times

Shareholding Pattern

Numbers in percentages

Sep 2021Mar 2022Sep 2022Mar 2023May 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
71.02% 71.02% 70.58% 70.54% 71.46% 71.46% 71.23% 68.44% 68.52% 68.61%
28.98% 28.98% 29.42% 29.46% 28.54% 28.54% 28.77% 31.56% 31.48% 31.39%
No. of Shareholders 496460291270258233226335333345

Documents

Announcements

Annual reports